New data providing further understanding on Cladribine ... - News-Medical.Net

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service65 times read : Adjust font size: Decrease font Enlarge font
image

EMD Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that new data providing further understanding on Cladribine Tablets as a potential new therapeutic option for relapsing forms of multiple sclerosis (MS) were presented at the ...

Read this article...



Post your comment comment Comments (0 posted)

copyright